The Index
400 dossiers · 1 need attention
A research screener for every company we cover. Search a name or ticker, then sort and triage dossiers by coverage freshness, our conviction and trading relevance.
| A de-risked computational-discovery option on AstraZeneca's rilvegostomig — the last surviving TIGIT bet — wrapped around a $135M cash shell and a binary 2027 ovarian readout; you are buying the royalty stream and the platform, not COM701. | — | 0 |